Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling - FDA Safety Alerts & Drug Recalls

Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level.

from Food and Drug Administration--Recalls/Safety Alerts http://bit.ly/2Pod3ui
via IFTTT